| 1 |
35420725 | Losartan treatment improves recessive dystrophic epidermolysis bullosa: A case series. | 2022 Apr 14 |
1 |
| 2 |
35421526 | Corneal fibroblast collagen type IV negative feedback modulation of TGF beta: A fibrosis modulating system likely active in other organs. | 2022 May |
2 |
| 3 |
33252490 | Losartan to reduce inflammation and fibrosis endpoints in HIV disease. | 2021 Mar 15 |
1 |
| 4 |
32434573 | Antifibrotic therapy to normalize the tumor microenvironment. | 2020 May 20 |
1 |
| 5 |
32698527 | Pro-Fibrotic Phenotype in a Patient with Segmental Stiff Skin Syndrome via TGF-β Signaling Overactivation. | 2020 Jul 20 |
1 |
| 6 |
33511129 | Modeling Uremic Vasculopathy With Induced Pluripotent Stem Cell-Derived Endothelial Cells as a Drug Screening System. | 2020 |
1 |
| 7 |
31404091 | Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B. | 2019 |
1 |